VANDA PHARMACEUTICALS INC (VNDA) Stock Analyst Ratings
NASDAQ:VNDA - Nasdaq - US9216591084 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to VNDA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.02. This target is 147.61% above the current price.
VNDA was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VNDA.
In the previous month the buy percentage consensus was at a similar level.
VNDA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Initiate | Buy |
| 2024-08-01 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-07-11 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-02-25 | Jefferies | Downgrade | Buy -> Hold |
| 2021-05-12 | B of A Securities | Initiate | Buy |